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Transplant glomerutopathy: Evolution of morphologicatly distinct
changes. The study was undertaken to redefine morphological appear-
ance and clinical implications of the diagnosis of transplant
glomerulopathy (TGP). Fifty-seven renal transplant biopsy specimens
from thirty patients with the diagnosis of TGP were evaluated. Multiple
repeat biopsies in several cases enabled us to follow the pattern of the
evolution of the changes. Transplant dysfunction manifested itself 8
days to 13 years post-transplantation by proteinuria and/or elevated
creatinine level. The earliest recognizable morphological change was
the swelling of endothelial and mesangial cells. This stage was called
evolving TGP. The intermediate stage was characterized by enlarged
glomeruli with lobular simplification, spongy matrix, and glomerular
basement membrane (GBM) deformities. The advanced stage of TOP
showed pronounced GBM changes (reduplication, interposition). These
light microscopic changes were associated with vascular rejection.
Imniunofluorescence showed significant glomerular deposition of 1gM
(83% of biopsies) and fibrinogen (66%). Electron microscopy at an early
stage showed subendothelial widening with cellular debris and focal
endothelial damage with fibrin deposition. In the advanced stage,
complex GBM changes developed as a reparative response to the
capillary wall injury. Effacement of foot processes was a constant
finding at all stages. In follow-up, twenty-three allografts failed (77%),
five patients are stable, and two died due to other causes. TGP has
specific morphology with an attendant poor long-term prognosis for the
allograft.
Glomérulopathie du transplant: Evolution de changements morpholo-
giquement distincts. Cette étude a été entreprise pour redéfinir l'aspect
morphologique et les implications cliniques do diagnostic de
glomérulopathie du transplant (TOP). Cinquante-sept specimens
biopsiques de transplants rénaux provenant de trente malades porteurs
du diagnostic de TGP ont etC évaluées. Des biopsies répétées de
multiples fois dans plusieurs cas nous ont permis de suivre l'aspect
évolutif des modifications. Le dysfonctionnement du transplant se
manifestait lui-méme de 8jours a 13 ans après Ia transplantation par une
protéinurie et/ou un niveau de crCatinine ClevC. La modification
morphologique reconnaissable Ic plus prCcocCment Ctait un gonfiement
des cellules endothCliales et mesangiales. Ce stade Ctait appelC TGP en
apparition. Le stade intermCdiaire était caractCrisC par des glomCrules
de taille accrue, avec une simplification lobulaire, une matrice
spongieuse, et des deformations de Ia membrane basale glomerulaire
(GBM). Le stade avancé de TGP présentait des modifications
prononcées de Ia GBM (déboublement, interposition). Ces modifica-
tions en microscopie optique étaient associées a un rejet vasculaire.
L'immunofiuorescence révClait des dépôts glomCrulaires significatifs
d'IgM (83% des biopsies) et de fibrinogene (66%). La microscopic
Clectronique a un stade precoce rCvélait un épaississement sous-
endothélial avec des debris cellulaires et des lesions endothéliales
locales avec depots de fibrine. Au stade avancC, des modifications
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complexes de Ia GBM se développaient a titre de réponse reparative
aux alterations de la paroi capillaire. L'effacement des pédicelles était
un fait constant a tous les stades. Lors du suivi, vingt trois allogreffes
ont échoué (77%), cinq malades sont stables, et deux sont décCdées
d'autres causes. TGP a une morphologic specifique avec un pronostic
associé a long terme défavorable pour l'allogreffe.
Glomerular changes unique to renal allografts and manifested
by transplant dysfunction (proteinuria, elevated serum creati-
nine) were first reported approximately 20 years ago [1—4]. In
1971, Busch, Galvanek, and Reynolds [5] termed these changes
"rejection transplant glomerulopathy" and differentiated them
from chronic ischemic changes and de novo or recurrent
glomerulonephritis. To our knowledge, Zollinger et al [6] were
the first to use the term "transplant glomerulopathy" (TGP)
which they used to identify a constellation of specific histologi-
cal, ultrastructural and immunofluorescence findings in long-
surviving cadaver transplant patients. He clearly defined mor-
phological criteria for the diagnosis and differentiated them
from other glomerular changes that may occur in transplants
[6].
Surprisingly, during the past several years the term "trans-
plant glomerulopathy" has been either completely forgotten [7]
or loosely applied to a wide variety of unrelated glomerular
alterations. With the continuously expanding numbers of long-
term surviving transplant patients, there is an increasing preva-
lence of transplant dysfunction occurring several to more than
10 years post-transplantation because of various causes. The
spectrum includes cellular and vascular rejection, de novo and
recurrent glomerulonephritis, recurrent diabetic glomerulo-
sclerosis, renal vein thrombosis, and renal artery stenosis.
There is also a distinct group that is different from these others
and fits a category referred to as transplant glomerulopathy.
Because controversy still exists regarding the morphologic
expression and significance of this entity, it seemed important
and worthwhile to analyze the clinical and pathological data
from cases of TGP we have studied.
Methods
Between 1967 and 1984, 696 kidney transplants were per-
formed at the University of Cincinnati Medical Center and The
Christ Hospital, Cincinnati, Ohio, USA. In 30 cases, a biopsy
diagnosis of transplant glomerulopathy was made. Allograft
dysfunction developed in these cases at various periods post-
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transplantation (ranging from 8 days to 13 years) and was
manifested clinically by either proteinuria (ranging from 1.6 to
7.8 g/24 hr) and/or elevated serum creatinine levels (ranging
from 1.3 to 10.0 g/dl) (Table 1). The patient population consisted
of 17 males and 13 females—6 Blacks, 21 Caucasians, 2
Orientals, and 1 Arab; 22 received cadaveric transplants and 8
living, related-donor transplants. Original renal failure prior to
transplantation was caused by chronic glomerulonephritis (16),
diabetic glomerulosclerosis (6), hypertensive riephrosclerosis
(2), urinary tract obstruction (2), polycystic kidney disease (1),
chronic interstitial nephritis (1), and two unknown.
Immunosuppressive therapy consisted of azathioprine and
corticosteroids. Azathioprine, 4 mg/kg, was given intrave-
nously on the day of surgery. Thereafter, it was given orally in
a dose of 2 mg/kg/day. The dose was reduced if the white blood
count fell below 5,000/mm3 and in the presence of renal
insufficiency. The dose of corticosteroids has been reduced
markedly over the years, reflecting the general trend toward the
use of lower maintenance doses following renal transplantation.
The current regimen consists of methylprednisolone, 250 mg
i.v. on the day of surgery, followed by an oral dose of
prednisone, 120 mg the following day. The dose is then reduced
rapidly to 30 mg of prednisone by day 13, and to 20 mg at 6
months, and then 10 mg by 1 year. In recipients of HLA-
identical kidneys it has been our policy to discontinue predni-
sone after 1 year [8]. Rejection episodes were treated with 250
mg of methylprednisolone intravenously daily for 4 days.
Antilymphocyte globulin or antithymocyte globulin in a dose of
15 mg/kg/day for 10 days was used either prophylactically or for
treatment of acute rejection episodes.
Monitoring for cytomegalovirus (CMV) infection was carried
out by measuring antibody titers before transplantation and at
regular intervals following transplantation in most patients.
Cultures of throat, blood, and urine for CMV were performed in
the presence of an elevated temperature in all patients in whom
an otherwise unexplained cause of fever occurred. A diagnosis
of active CMV infection was made by the presence of a positive
culture and/or fourfold rise in antibody titer.
Pathological materials and methods
Histopathological evaluation involved 57 tissue specimens
(biopsy and nephrectomy specimens). In 83% of the cases,
more than one specimen was available for pathological studies.
The tissue specimens obtained by biopsy and/or nephrectomy
were fixed in Mossman's solution (for light microscopy), rou-
tinely processed and paraffin-embedded, Three-micron thick
serial sections were stained with hematoxylin and eosin, Jones'
methenamine silver, the Frasier modification of the Lendrum
Biopsy done (period
post-tx)Patient
no. Days Months
Table 1.
Tx dysfunction manifested
byb
Proteinuria Elevated cr
g/24 hr gidi Clinical follow-up time post-transplantation
1 8 36 3.5 2.8 Nephrectomy at 45 months
2 3,9 3,4 1.1 13.0 Nephrectomy at 4 months
3 12 — 2.2 Stable at 8 months; cr 1.5, no proteinuria
4 18,26 1.0 8.6 Nephrectomy at 28 daysa
5 21,35 5.3 5.6 Nephrectomy at 50 days
6 34 Y' — 2.6 Unstable at 7 months; cr 6.7, prot 2.0; on dialysis 2 months later
7 35 2.5a 4.2 1.4 Stable at 14 months; cr2.8, prot 2.8
8 35 3 — 3.6 On dialysis at 2 months
9 41 4 1.3 4.0 Nephrectomy at 5 months
10 42a,56a 0.7 4.7 Nephrectomy at 60 days
11 45 5.2 2.0 On dialysis at 3 years
12 49 3,8 3.2 Nephrectoniy at 2 monthsa
13 2 7.2 4.6 Stable at 22 months; cr2.1, prot 3.8
14 77 4.5 1.6 3.0 Nephrectomy at 41 months
15 3a,13 2.7 1.8 On dialysis at 11 months; nephrectomy 2 months later
16 4 2.2 2.1 Nephrectomy at 5 months
17 6 3.0 Nephrectomy at 7 months
18 17 5.7 1.3 Died due to other causes 3 weeks later
19 21 4.0 10 On dialysis at 25 months
20 24a,28a 2.6 1.8 On dialysis
21 24a,27 2.0 2.0 Died at 27 months (DIC)
22 36 — 3.7 On dialysis at 43 months
23 36 — 5.0 Nephrectomy at 36 months
24 42 — 6.0 On dialysis
25 62 0.3 3.5 On dialysis at 63 months
26 84a,90 1.3 5.2 On dialysis at 92 months
27 101 4.0 2.2 Stable at 138 months; cr2.8, prot 2.4
28 120 2.5 3.8 On dialysis at 128 months
29 120 6.0 3.6 Nephrectomy at 124 months
30 156 0.5 4.1 Stable at 172 months; cr2.6
Abbreviations: tx, transplantation; cr, creatinine; prot, proteinuria.
a Electron microscopy was done.
b At the time of the first biopsy.
stain for fibrin, and Masson's trichrome. Slides were studied
independently by two pathologists. Tissue specimens from
forty-one biopsies were snap-frozen in OCT for immunoflu-
orescence studies and were stained with fluoroscein conjugated
antisera to IgG, IgA, 1gM, C3 and fibrinogen (Cappel Lab).
Deposits were recorded as focal or diffuse, mesangial and/or
capillary wall and semiquantitatively graded from trace to 4+.
Tissue for electron microscopic examination was processed by
standard techniques and embedded in Epon. Thirty-one
glomeruli were available for study in 26 biopsy specimens.
Sections were stained with uranyl acetate and lead citrate and
examined by an electron microscope (Zeiss 9S).
Clinical results
The outcome in these 30 patients is shown in Table I. Only
five patients, numbered 3, 7, 13, 27,and 30, have stable allograft
function. These patients have been followed for 8, 13, 20, 37
and 16 months, respectively, since the histologic diagnosis of
TGP was made. In 12 patients, transplant nephrectomy was
performed, 11 returned to dialysis, and two died of unrelated
causes (both had functioning allografts at the time of their
death).
Of the 30 patients with transplant glomerulopathy, informa-
tion on CMV infection was available in 21. Evidence for active
CMV infection occurred in 14 of the 21 patients (67%) as
compared to 60% incidence of CMV infection in our general
transplant patient population.
Pathological results
Light microscopy and electron microscopy. The earliest
glomerular morphological change was diffuse and prominent
swelling of endothelial and mesangial cells resulting in dimin-
ished patency of the capillary loops (Fig. 1). Glomeruli were
often enlarged. These changes were found when the first biopsy
specimen was obtained 8 to 83 days post-transplantation (see
Table 1). There was no increase in mesangial matrix and
glomerular basement membranes (GBMs) appeared nor-
mal. This early stage is termed "evolving transplant
glomerulopathy."
The ultrastructural appearance of glomeruli at an early stage
correlated very closely with the light microscopic picture.
Endothelial cells were reactive with abundant cytoplasm
packed with prominent organelles, and frequently occluded
or significantly diminished the patency of capillary lumens.
Mesangial zones were expanded slightly with matrix containing
abundant cellular and particulate debris. GBMs were unremark-
able. Isolated loops contained aggregates of activated platelets
(Fig. 2).
Consecutive biopsy specimens of the same allograft obtained
after a several weeks interval (patient 2 and 8 at 3 months,
patient 4 at 26 days, patient 6 at 83 days, patient 7 at 50 days)
consistently showed enlarged glomeruli with lobular simplifica-
tion and swollen endothelial and mesangial cells (Fig. 3). At this
intermediate stage, silver staining delineated focal and subtle
GBM changes characterized by vacuolization or reticulation,
and in occasional loops partial "reduplication" (double con-
tours). A characteristic spongy appearance of expanded mesan-
gial zones consisting of swollen mesangial cells embedded in
delicate, fine, silver-positive network (Fig. 3) was seen in
biopsy specimens taken at 2, 6, 7 months post-transplantation
Fig. 1. Micrograph from patient 4 (at 18 days post-transplantation)
exhibiting evolving TGP. (x265)
(patients 9, 10, 12, 14, and 17) and was a consistent finding in
biopsies performed between 21 and 62 months after transplanta-
tion. Mesangial hypercellularity and increase in matrix, if
present, were very focal and mild. This is the intermediate stage
of TGP. Mesangiolysis was a rare finding, but when seen focally
at this stage (patient 23) was characterized by segmental dis-
solution of mesangial zones and GBMs that were often bounded
by intact GBMs.
Patients 7, 10, and 21 provided the opportunity to study
active damage of the glomerular capillary wall at various time
intervals (see Table 1). By light microscopy, the glomerular
lesions in the first two cases were those of evolving transplant
glomerulopathy while in the third case the characteristic
changes of advanced TGP were present. In all three cases,
fibrin was focally present in single loops of a few glomeruli (on
Lendrum-stained sections). Active damage was found in iso-
lated loops only in three of the total of seven glomeruli available
in these cases for electron microscopy. Among capillary loops
with reactive endothelial changes, focal disintegration of the
capillary wall structure was found. GBMs had a thin intact
lamina densa and subendothelial zones filled with degenerated
and necrotic endothelial cell fragments, abundant cellular and
particulate debris (Fig. 4A) intermixed with prominent fibrin
tactoids and fibrinoid material (Fig. 411). These damaged loops
either had no endothelial lining or only remnants of degenerated
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Fig. 2. Micrograph from patient 12 (at 49 days) exhibiting evolving
TGP. Intracapillary aggregated platelets (arrows) with effacement of
foot processes. (x3033)
and necrotic endothelial cell cytoplasm (Fig. 4B). Deposition of
fibrin was also present in a few mesangial zones with cellular
degeneration and necrosis. In other loops, there was evidence
of reparative stage of injury characterized by GBMs (patients 7
and 10) with a widened subendothelial zones containing cellular
debris and already separated from the lumen by an irregular
layer of finely fibrillary new basement membrane material
covered by endothelium (Fig. 5).
The fully developed morphological appearance of transplant
glomerulopathy (advanced stage) was seen in biopsy specimens
taken several years post-transplantation (patients 18 to 30). The
glomeruli remained enlarged with prominent swollen endothe-
hal cells and spongy expansion of the mesangial matrix. GBM
changes became very pronounced in the form of reticulation,
vacuolization, and prominent complete and incomplete redupli-
cation (Fig. 6).
Reconstruction of evolution of the changes was facilitated by
the fact that in six allografts we had tissue for electron micros-
copy from two consecutive biopsies (patients 1, 4, 5, 7, 10, and
20). Initial biopsy specimens exhibited evolving TOP, while in
repeat biopsies there were features of intermediate stages of
TGP. Electron microscopy showed reparative changes involv-
ing mesangial zones and peripheral capillary walls. Mesangial
zones were expanded with reactive mesangial cells and large
Fig. 3. Micrograph from patient 2 (at 3 months) exhibiting the inter-
mediate stage of TGP. Spongy matrix is represented by SM. (x550)
areas of finely fibrillar new basement membrane material with
cellular and particulate debris. GBMs had prominent double
contours with preserved lamina densa separated from a suben-
dothelial layer of new basement membrane material by a wide
electron lucent zone of finely fibrillar or flocculent substance. In
some loops, this zone contained extensions of mesangial cell
cytoplasm (interposition) resulting in reduplication (Fig. 7).
Regardless the stage of development of TGP, effacement of foot
processes, irregular or extensive, was a constant ultrastructural
finding in all the biopsy specimens (see Figs. 1, 2, 4, 5, and 7).
In several cases, regardless of the time post-transplantation
when the biopsy was taken, sections stained with Lendrum
showed small amounts of fibrin in single capillary loops or in
pre-glomerular arterioles. Few glomeruli had cellular crescents.
An occasional small glomerulus or geographically grouped
glomeruli with ischemic wrinkling of GBMs and collapsed loops
was infrequently seen and did not display any of the character-
istic changes described above. In one case, enlarged glomeruhi
with characteristic changes of transplant glomerulopathy
showed superimposed ischemic wrinkling of reduplicated
GBMs.
The light microscopic glomerular changes were always as-
sociated with variable degrees of vascular rejection. In the early
post-transplantation period, vascular endothelium was swollen
and occasionally fibrin deposition was present. Later, myo-
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Fig. 4. Micrographs from patient 10 (at 42 days) exhibiting active damage. A Necrotic endothelium (END). Other abbreviations are: cellular debris
in subendothelial and mesangial zones, d; fibrin, f. (x6066) B Glomerular basement membrane (GBM). Other abbreviations are: fibrin tactoids,
f; remnants of endothelium, END. (x 15171)
intimal proliferation with mononuclear inflammatory infiltra-
tions caused diminished patency of the arterial lumen. Finally,
in the long-surviving transplants, intimal fibrosis usually re-
placed myointimal proliferation, and foam cells were often
present.
Immunofluorescence. 1gM was most consistently found (in
85% of the biopsy specimens) and was present diffusely (2+ to
3+) in mesangial zones in a granular pattern, with only oc-
casional capillary wall deposits. Whenever vessels were sam-
pled, 1gM was also present in arterial intima and media.
Fibrinogen was present irregularly and focally in trace to 2+
amounts in capillary walls and/or mesangial zones (in 67% of
the biopsy specimens). Focal arteriolar and arterial thrombi
were also present.
Linear 1 + to 2+ staining of GBMs with IgG was present in
ten patients (25%), four of whom were diabetic patients. An
additional three biopsy specimens showed an irregular trace to
1 + granular capillary or mesangial deposits of IgG. In 25 biopsy
specimens (62%) there was arteriolar deposition of C3. Very
focal and usually segmental granular mesangial or capillary wall
deposition of trace amounts of C3 was found in only 14 patients.
C3 did not associate with significant deposition of immunoglob-
ulins in any of them, nor did it form a consistent pattern.
Discussion
The literature of the past few years still reflects confusion and
controversy regarding the morphology and pathogenesis of
TGP. Observations representing individual features of TGP
have been nonspecifically and inconsistently incorporated into
a wide spectrum of glomerular changes in allografts, such as
chronic rejection [9], GBM and mesangial thickening [101, and
a combination of atrophy and rejection [11]. In recent years, the
changes of TGP have even been referred to as "having a very
polymorphous picture including components of several types of
idiopathic native glomerulonephritis" [12], or a stage in devel-
opment of focal segmental sclerosis [13], and finally as a specific
CMV-associated glomerulopathy [14].
TGP emerged as a distinct group of cases with specific
morphology in our evaluation of various causes of post-
transplant proteinuria [15—171. Repeat biopsies in several pa-
tients enabled us to follow the pattern of evolution of the
changes from early to the advanced ones. Diffuse endothelial
cell swelling was the earliest recognizable feature of TGP in our
material and persisted through its evolution to the advanced
stage. The same observations were made by other authors
[1—4], but Zollinger et al [6] were the ones who pointed out its
prominence as "the most eye-catching change in TGP."
;.trt aI-
— ';'tm
'I
— atr
.1
4
'S
A
ctp
'1
804 Maryniak et al
Fig. 5. Micrograph from patient 23 (at 36 months) exhibiting the
intermediate stage of TGP. Abbreviations are: A, original basement
membrane; B, widened zone filled with cellular debris: C, new layer of
basement membrane material ("reduplication"). (x24590)
Most authors disagree about mesangial changes and give very
contradictory data [4—6, 12]. In our material, prominence of
swollen mesangial cells, which closely followed endothelial
swelling, was a consistent finding. How do these early reactive
endothelial and mesangial changes relate to the characteristic
appearance of advanced TGP with spongy matrix and GBM
deformities? Occasional aggregated platelets and fibrin deposi-
tion in patients 7, 10, and 21, who exhibited active damage of
capillary loops, provided the most likely explanation for the
pathogenesis of their evolution. Similar findings were noted by
Porter et al [4] who suggested that the deposition of degran-
ulated platelets and fibrin cause endothelial injury with subse-
quent repair by developing new basement membrane material
and regenerating endothelium. This reparative process takes
place within a widened subendothelial zone with entrapped
abundant cellular fragments and debris [18]. The role of fi-
brinogen or its degradation products causing these lesions has
been implicated strongly by experimental studies [19], as well
as by consistent although focal finding of fibrin in glomeruli by
immunofluorescence [20, 21]. Busch, Galvanek, and Reynolds
[5] suggested repetitive episodes of microthrombosis as the
pathogenetic mechanism for development of reparative changes
in the capillary walls. Patient 21 seems to support the statement
Fig. 6. Micrograph from patient 9 (a 5 months) exhibiting advanced
TGP. Reduplicated GBMs are noted by the arrows, (x500)
of Zollinger et al [6] that repetitive episodes of endothelial
injury may occur over the period of years in subclinical form.
The appearance of glomeruli with reduplicated GBMs in
kidney allograft morphology is characteristic and specific for
TGP. However, as such, it is not pathognomonic [13] because
the similar appearance of reparative stage of glomerular injury
may be encountered in thrombotic microangiopathy and other
coagulation disorders [22, 23]. Patient 29 exhibits these diag-
nostic difficulties, A 21-year-old pregnant woman, 10 years after
having a kidney transplantation, presented in labor with severe
hypertension, proteinuria, and deterioration of renal function.
The initial biopsy changes were indistinguishable from pre-
eclamptic toxemia; however, progressive deterioration in renal
function occurred, and the transplanted kidney was removed 4
months later. Histology of the nephrectomy specimen revealed
chronic vascular rejection and persisting glomerular injury
consistent with TGP.
The mesangium is involved in the same repetitive process of
injury and repair as capillary walls, and fibrin plays an active
role [4—6]. Mesangial cells are involved in digestive degradation
of various materials which, in condensed form, remain in
paramesangial zones as electron dense deposits [24, 25]. These
deposits do not represent immune complexes, although they
may resemble them, but consist of a mixture of plasma proteins,
cellular and particulate debris and fibronectin [251. Mesangial
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of whom had typical viral inclusions in other organs, was there
any evidence of glomerulopathy. The third group consisted of
renal transplant patients with renal biopsy specimens showing
glomerular changes comparable with those reported by
Richardson et al [141. However, immunofluorescence and elec-
tron microscopy did not substantiate active cytomegalovirus
renal infection. We agree with the conclusion of Herrera et al
[26] and do not think that the disputed entity is a CMV specific
glomerulopathy. Extensive studies on active CMV infection in
the renal transplant recipients report high incidences ranging
between 50 and 75% [27, 28] and list it as 'the single most
commonly recognized infectious disease in the first year post
transplantation" [271. At the same time, TGP is not a common
diagnosis. In our series, TGP was diagnosed in only 4.3% of the
patients (30 of 696 patients).
in conclusion, TGP may be diagnosed easily by light micros-
copy due to the characteristic morphological appearance. It is
associated consistently with vascular rejection. The pathologic
diagnosis of TGP carries serious clinical implications and a poor
long-term prognosis.
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Fig. 7. Micrograph from patient 9 (at 5 months) exhibiting advanced
TGP with reparative GBM deformities. Abbreviations are: A, original
basement membrane; B, interposition of mesangial cell cytoplasm; C,
new layer of basement membrane material ("reduplication"). (x3285)
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